Heart Failure: Mechanisms and Therapies

Web Desc
Heart Failure: Mechanisms and Therapies - RESCHEDULING IN PROGRESS
joint with Mitochondria, Metabolism and Heart - RESCHEDULING IN PROGRESS
Scientific Organizers: David A. Kass and Saptarsi M. Haldar
Date: January 14 - 18, 2021
Location: Eldorado Hotel & Spa, Santa Fe, NM, USA
Supported by the Directors' Fund
For important information on the coronavirus, please click here
Summary of Meeting:
Heart failure (HF) is a leading global cause of morbidity and mortality. As life expectancy increases, individuals are experiencing the compounded effects of accumulated disease, genetic propensity, environmental stress, and behavior. The underpinnings of HF are multifactorial, providing a broad array of relevant biochemical therapeutic targets that could impact clinical symptoms and outcomes. Aging, the obesity epidemic and associated disorders, such as diabetes, have a major impact on heart failure pathophysiology. The roles of altered metabolism, mitochondrial dysfunction, protein quality control, inflammation, and fibrosis as well as the latest methods for single-cell analysis of subpopulations studies on epigenetic control of disease and heart development/regeneration will be featured. The dawn of a new age in manipulation of heart contractions is upon us and this conference will enable discussion of recent advances in HF treatment, including clinical testing. Many of the speakers will be leaders in highly relevant fields that are not often among those featured at a typical HF conference. One of the goals is to encourage dialog and foster interdisciplinary collaboration between researchers in fields that all have have relevance to a failing heart. Lastly, this conference is being paired with another Keystone Symposia conference on Mitochondria, Metabolism and Heart, which will also have a cardiac emphasis. There will be two joint sessions that will focus on mitochondrial function and metabolism, respectively.
We gratefully acknowledge the generous grant for this conference provided by:

National Heart, Lung, and Blood Institute (NHLBI)
Grant No. 1R13HL154588-01
Funding for this conference was made possible (in part) by 1R13HL154588-01 from the National Institutes of Health. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention by trade names, commercial practices, or organizations imply endorsement by the U.S. Government.
We appreciate the organizations that provide Keystone Symposia with additional support, such as marketing and advertising:

Click here to view more of these organizations
Special thanks to the following for their support of Keystone Symposia initiatives to increase participation at this meeting by scientists from underrepresented backgrounds:

Click here to view more of these organizations

No content found

No content found

No content found

No content found